Biofluid-Derived Exosomal LncRNAs: Their Potential in Obesity and Related Comorbidities
2024

Exosomal LncRNAs and Their Role in Obesity

Sample size: 150 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ngowi Ebenezeri Erasto, Lu Tuyan, Liu Qing, Xie Xianghong, Wang Ning, Luo Liping, Deng Lijuan, Zhou Yinghua, Zhang Zhihong, Qiao Aijun

Primary Institution: Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Hypothesis

Exosomal long non-coding RNAs (exo-lncRNAs) are altered in the biofluids of patients with metabolic disorders and correlate with key metabolic parameters.

Conclusion

Exosomal lncRNAs have potential as biomarkers for monitoring and managing obesity and related metabolic diseases.

Supporting Evidence

  • Exosomal lncRNAs are significantly altered in obesity and correlate with metabolic parameters like BMI and insulin resistance.
  • Exercise and dietary interventions can influence the levels of exosomal lncRNAs.
  • Exosomal lncRNAs have been linked to various metabolic diseases, including type 2 diabetes and metabolic syndrome.

Takeaway

Exosomes are tiny bubbles that carry important messages between cells, and special types of these messages, called lncRNAs, can help us understand and treat obesity.

Methodology

This review analyzes existing studies on exosomal lncRNAs in biofluids related to obesity and metabolic disorders.

Limitations

The field remains underexplored, particularly regarding biofluids beyond blood and the mechanisms of lncRNA action.

Participant Demographics

The study references data from over 1 billion people affected by obesity, including nearly 880 million adults and approximately 160 million children and adolescents.

Digital Object Identifier (DOI)

10.3390/biology13120976

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication